2016
2015
- New Cancer Therapies for the 21st Century: A Two Decade Review of Approved Drugs and Drugs in Development in the United States
- Giant-cell tumor of bone: treatment options and role of denosumab
- Anticancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab
- First-Line Aldoxorubicin vs Doxorubicin in Metastaticor Locally Advanced Unresectable Soft-Tissue Sarcoma A Phase 2b Randomized Clinical Trial
2014
2013
2012
2010
- Pathotropic targeting advances clinical oncology: Tumor-targeted localization of therapeutic gene delivery
- A Phase I/II Study of Intravenous Rexin-G and Reximmune-C for Cancer Immunotherapy: The GeneVieve Protocol
- A phase I/II study of intravenous Rexin-G and Reximmune-C for cancer immunotherapy: The GeneVieve protocol
- Advanced Phase I/II Studies of Targeted Gene Delivery In Vivo: Intravenous Rexin-G for Gemcitabine-resistant Metastatic Pancreatic Cancer
2009
Next, meet our doctors.